Test ID CD4RT CD4 T-Cell Recent Thymic Emigrants, Blood
Useful For
Evaluating thymic reconstitution in patients following hematopoietic cell transplantation, chemotherapy, immunomodulatory therapy, and immunosuppression
Evaluating thymic recovery in patients who are HIV-positive and on highly active antiretroviral therapy
Evaluating thymic output in patients with DiGeorge syndrome or other cellular immunodeficiencies
Assessing the naive T-cell compartment in a variety of immunological contexts (autoimmunity, cancer, immunodeficiency, and transplantation)
Identification of thymic remnants post-thymectomy for malignant thymoma or as an indicator of relapse of disease (malignant thymoma) or other contexts of thymectomy
Special Instructions
Method Name
Flow Cytometry
Reporting Name
CD4 RTE, Flow CytometrySpecimen Type
Whole Blood EDTAShipping Instructions
Testing is performed Monday through Friday. Specimens not received by 4 p.m. (CST) on Friday may be canceled.
Samples arriving on the weekend and observed holidays may be canceled.
Collect and package specimen as close to shipping time as possible. Ship specimen overnight in an Ambient Shipping Box-Critical Specimens Only (T668) following the instructions in the box.
It is recommended that specimens arrive within 24 hours of collection.
Necessary Information
Ordering healthcare professional name and phone number are required.
Specimen Required
Supplies: Ambient Shipping Box-Critical Specimens Only (T668)
Container/Tube: Lavender top (EDTA)
Specimen Volume: 3 mL
Collection Instructions: Send whole blood specimen in original tube. Do not aliquot.
Specimen Minimum Volume
1.5 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Whole Blood EDTA | Ambient | 48 hours | PURPLE OR PINK TOP/EDTA |
Reference Values
CD4 Absolute
Males
1 month-17 years: 153-1745 cells/mcL
18-70 years: 290-1,175 cells/mcL
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
Females
1 month-17 years: 582-1630 cells/mcL
18-70 years: 457-1,766 cells/mcL
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
CD4 RTE %
Males
1 month-17 years: 19.4-60.9%
18-25 years: 6.4-51.0%
26-55 years: 6.4-41.7%
≥56 years: 6.4-27.7%
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
Females
1 month-17 years: 25.8-68.0%
18-25 years: 6.4-51.0%
26-55 years: 6.4-41.7%
≥56 years: 6.4-27.7%
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
CD4 RTE Absolute
Males
1 month-17 years: 50.0-926.0 cells/mcL
18-70 years: 42.0-399.0 cells/mcL
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
Females
1 month-17 years: 170.0-1007.0 cells/mcL
18-70 years: 42.0-832.0 cells/mcL
Reference values have not been established for patients that are younger than 30 days of age.
Reference values have not been established for patients that are older than 70 years of age.
Day(s) Performed
Monday through Friday
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86356
LOINC Code Information
Test ID | Test Order Name | Order LOINC Value |
---|---|---|
CD4RT | CD4 RTE, Flow Cytometry | In Process |
Result ID | Test Result Name | Result LOINC Value |
---|---|---|
89504 | CD4 Absolute (cells/uL) | 24467-3 |
29536 | CD4 RTE % | 8123-2 |
29535 | CD4 RTE Absolute | 24467-3 |
29178 | Interpretation | 69052-9 |
Test Classification
This test was developed using an analyte specific reagent. Its performance characteristics were determined by Mayo Clinic in a manner consistent with CLIA requirements. This test has not been cleared or approved by the US Food and Drug Administration.Report Available
3 to 4 daysNY State Approved
YesTesting Algorithm
For information see Newborn Screen Follow-up for Severe Combined Immunodeficiency Syndrome (SCID).